Table 1.
Groups | N | Treatment | ||
---|---|---|---|---|
Mitomycin Ce | Spheroidsf | Nanosheetg | ||
1. Untreated skin defecta | 8 | − | − | − |
2. Untreated RUb | 14 | + | − | − |
3. NS alone for RUc | 8 | + | − | + |
4. ASCs spheroids NS for RUd | 14 | + | + | + |
aNo treatment after removal of skin and subcutaneous tissue.
bNo treatment for mitomycin C-induced refractory ulcer.
cTreatment by the nanosheet without ASC spheroids for mitomycin C-induced refractory ulcer.
dTreatment by the nanosheet carrying ASC spheroids for mitomycin C-induced refractory ulcer.
eTopical application of mitomycin C onto the wound.
fTransplantation of 2 × 102 spheroids onto the wound.
gApplication of a nanosheet onto the wound.